pyridostigmine
CAS No. 155-97-5
pyridostigmine ( Pyridostigminum,Regonol,Mestinon-SR )
Catalog No. M22264 CAS No. 155-97-5
Pyridostigmine?is an?acetylcholinesterase inhibitor?that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 178 | In Stock |
|
5MG | 268 | In Stock |
|
10MG | 408 | In Stock |
|
25MG | 672 | In Stock |
|
50MG | 945 | In Stock |
|
100MG | 1278 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Namepyridostigmine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPyridostigmine?is an?acetylcholinesterase inhibitor?that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
-
DescriptionPyridostigmine?is an?acetylcholinesterase inhibitor?that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.Pyridostigmine holds promise for the treatment of various gastrointestinal symptoms in SSc patients, particularly in patients with refractory constipation. Though side effects may limit its use, most patients who experienced benefit chose to continue therapy.
-
SynonymsPyridostigminum,Regonol,Mestinon-SR
-
PathwayOthers
-
TargetOther Targets
-
Recptoracetylcholinesterase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number155-97-5
-
Formula Weight261.12
-
Molecular FormulaC9H13BrN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ahuja N K , Mische L , Clarke J O , et al. Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis[J]. Semin Arthritis Rheum, 2018:S0049017217305498.
molnova catalog
related products
-
Leteprinim
Leteprinim is an hypoxanthine derivative that stimulates in vitro neurite outgrowth and the production of adenosine and neurotrophins from astrocytes.
-
CCTA-1523
CCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.
-
3',4',5',5,7-Pentame...
It is an organic compound with fomular C20H22O7.